| Trial ID: | L0846 |
| Source ID: | IRCT2016042827652N1
|
| Associated Drug: |
Ginger
|
| Title: |
The effect of ginger powder supplement on lipid profile, insulin resistance, antioxidant status, inflammatory biomarkers and fatty liver index in owerweight and obese patients with Nonalcoholic fatty liver disease(NAFLD).
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Fatty Liver Disease. <br>Fatty (change of) liver, not elsewhere classified;Fatty (change of) liver, not elsewhere classified
|
| Interventions: |
Intervention 1: intervention group:Three ginger capsules 500 mg daily for 12 week. Intervention 2: The placebo group:Three placebo daily for 12 weeks.;Treatment - Drugs;Placebo;intervention group:Three ginger capsules 500 mg daily for 12 week;The placebo
|
| Outcome Measures: |
Liver steatosis index. Timepoint: Before and after intervention. Method of measurement: Sonography.;Insulin Resistance (IR). Timepoint: Before and after intervention. Method of measurement: Based on HOMA IR equation.;Liver enzymes (ALT, AST, ALP, GGT???). Timepoint: Before and after intervention. Method of measurement: Microgram/ml - laboratory kit.;Tomor necrosis factor alpha (TNF alpha). Timepoint: Before and after intervention. Method of measurement: ELISA.;Serum Total Anti Oxidant Capacity (TAOC). Timepoint: Before and after intervention. Method of measurement: ELISA.;High sensitive C reactive protein. Timepoint: Before and after intervention. Method of measurement: ELISA.;Fetuin A. Timepoint: Before and after intervention. Method of measurement: ELISA.;Lipid profile (TG, LDL, HDL, Total cholestrol). Timepoint: Before and after intervention. Method of measurement: laboratory kit.;Insulin. Timepoint: Before and after intervention. Method of measurement: ELISA.;Fasting Blood Sugar (FBS). Timepoint: Before and after intervention. Method of measurement: Colorimetric enzymatic method.Waist to hip ratio. Timepoint: Before and after intervention. Method of measurement: Non-stretchable tape without any pressure.;Body Mass Index (BMI). Timepoint: Before and after intervention. Method of measurement: Weight (kilograms) divided by the square of height (meters).;Sistolic and diastolic blood pressure. Timepoint: Before and after intervention. Method of measurement: By mercury sphygmomanometer.;Fatty liver index. Timepoint: Before and after intervention. Method of measurement: Based on the equation.
|
| Sponsor/Collaborators: |
Vice Chancellor for research of Ahvaz Jundishapur University of Medical Sciences
|
| Gender: |
All
|
| Age: |
20 years70 years
|
| Phases: |
Phase 3
|
| Enrollment: |
46
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
|
| Start Date: |
04/05/2016
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/22609
|
